• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促肾上腺皮质激素释放激素(CRH)在母体和胎儿血浆以及羊水中的结合情况。

Binding of corticotropin-releasing hormone (CRH) in maternal and fetal plasma and in amniotic fluid.

作者信息

Salminen-Lappalainen K, Laatikainen T

机构信息

Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Finland.

出版信息

Clin Chim Acta. 1990 Dec 31;195(1-2):57-66. doi: 10.1016/0009-8981(90)90194-w.

DOI:10.1016/0009-8981(90)90194-w
PMID:2093479
Abstract

Placenta secretes corticotropin-releasing hormone (CRH) into the maternal and fetal circulation, but a CRH binding protein in plasma may decrease its biological activity. Using a charcoal adsorption method we found that 92% of added 125I-Tyr-CRH was bound to a binding protein in the nonpregnant plasma, 72% in the plasma at term pregnancy, 90% in umbilical cord plasma, 82% in the amniotic fluid in the second and 25% in the third trimester. CRH added to plasma inhibited the binding of 125I-Tyr-CRH over the concentration range of 0.1-8.8 nmol/l in plasma and of 0.1-2.2 nmol/l in amniotic fluid. There was a significant negative correlation (R = -0.80) between the binding capacity of the CRH-binding protein and CRH concentration in maternal plasma. Plasma or amniotic fluid was incubated with 125I-Tyr-CRH and subjected to gel filtration on Sephadex G-50. The bound radioactivity was eluted at the region of Mr 25-40 kDa and the unbound radioactivity at the location of synthetic CRH. Bound and unbound CRH concentrations were determined using charcoal adsorption method and gel filtration on Sephadex G-50 in ten maternal plasma samples at the third trimester of pregnancy. Following mean percentages were found to be bound: charcoal method 61.9 +/- 6.80% (SE) and gel filtration 62.8 +/- 6.33%. We conclude that the bulk of CRH is bound to a binding protein in maternal and fetoplacental circulation, whereas at term pregnancy the role of the binding is small in amniotic fluid.

摘要

胎盘将促肾上腺皮质激素释放激素(CRH)分泌到母体和胎儿循环中,但血浆中的CRH结合蛋白可能会降低其生物活性。我们采用活性炭吸附法发现,添加的125I-酪氨酸-CRH中有92%与未孕血浆中的一种结合蛋白结合,足月妊娠血浆中为72%,脐带血浆中为90%,孕中期羊水为82%,孕晚期为25%。添加到血浆中的CRH在血浆浓度范围为0.1 - 8.8 nmol/l以及羊水浓度范围为0.1 - 2.2 nmol/l时,可抑制125I-酪氨酸-CRH的结合。CRH结合蛋白的结合能力与母体血浆中CRH浓度之间存在显著负相关(R = -0.80)。将血浆或羊水与125I-酪氨酸-CRH一起孵育,然后在Sephadex G-50上进行凝胶过滤。结合的放射性物质在Mr 25 - 40 kDa区域洗脱,未结合的放射性物质在合成CRH的位置洗脱。在妊娠晚期的10份母体血浆样本中,使用活性炭吸附法和Sephadex G-50凝胶过滤法测定结合和未结合的CRH浓度。发现结合的平均百分比为:活性炭法61.9 +/- 6.80%(标准误),凝胶过滤法62.8 +/- 6.33%。我们得出结论,大部分CRH在母体和胎儿-胎盘循环中与一种结合蛋白结合,而在足月妊娠时,该结合在羊水中的作用较小。

相似文献

1
Binding of corticotropin-releasing hormone (CRH) in maternal and fetal plasma and in amniotic fluid.促肾上腺皮质激素释放激素(CRH)在母体和胎儿血浆以及羊水中的结合情况。
Clin Chim Acta. 1990 Dec 31;195(1-2):57-66. doi: 10.1016/0009-8981(90)90194-w.
2
Presence of CRH-binding protein in amniotic fluid and in umbilical cord plasma.羊水和脐带血浆中促肾上腺皮质激素释放激素结合蛋白的存在。
Acta Endocrinol (Copenh). 1991 Aug;125(2):165-9. doi: 10.1530/acta.0.1250165.
3
Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery.孕期、分娩期及产时人体血浆中的免疫反应性促肾上腺皮质激素释放激素
J Clin Endocrinol Metab. 1987 Feb;64(2):224-9. doi: 10.1210/jcem-64-2-224.
4
Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy.倍他米松体内作用对人类妊娠胎盘促肾上腺皮质激素释放激素的影响。
Am J Obstet Gynecol. 1998 Apr;178(4):770-8. doi: 10.1016/s0002-9378(98)70490-9.
5
Relationship between maternal and fetal corticotrophin-releasing hormone-41 and ACTH levels in human mid-trimester pregnancy.
J Endocrinol. 1987 Sep;114(3):497-501. doi: 10.1677/joe.0.1140497.
6
Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation.妊娠期人血浆和羊水促肾上腺皮质激素释放激素水平
Clin Endocrinol (Oxf). 1994 Feb;40(2):257-62. doi: 10.1111/j.1365-2265.1994.tb02477.x.
7
Second-trimester amniotic fluid corticotropin-releasing hormone and urocortin in relation to maternal stress and fetal growth in human pregnancy.孕中期羊水促肾上腺皮质激素释放激素和尿皮质素与人类孕期母体应激及胎儿生长的关系
Stress. 2017 May;20(3):231-240. doi: 10.1080/10253890.2017.1312336. Epub 2017 Apr 21.
8
Corticotrophin-releasing hormone-binding protein in human fetal plasma.人胎儿血浆中的促肾上腺皮质激素释放激素结合蛋白
J Endocrinol. 1995 Sep;146(3):395-401. doi: 10.1677/joe.0.1460395.
9
High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy.孕期母血和胎儿血浆中促肾上腺皮质激素释放激素免疫活性水平较高。
J Clin Endocrinol Metab. 1986 Nov;63(5):1199-203. doi: 10.1210/jcem-63-5-1199.
10
Response to corticotropin-releasing hormone during pregnancy in the baboon.狒狒孕期对促肾上腺皮质激素释放激素的反应。
J Clin Endocrinol Metab. 1990 Apr;70(4):925-9. doi: 10.1210/jcem-70-4-925.